Board meeting on Nov 2, 2026 to consider Q2 FY27 results

Results View source PDF Explain this filing

SPARC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.1%Reaction day

₹179.00

prior close

₹172.56

announcement price

In-mkt

timing

Nifty Microcap 250market-1.0%-2.0% vs market

Pharmaceuticals peers, median of 170sector-0.5%-2.6% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 2.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.4

15m

-0.3

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.1-1.0-2.0-0.5-2.6

Next day

-3.6-3.3-0.3-2.2-1.5

+0.0-2.9+2.9-1.1+1.1

+0.0-1.3+1.3+0.7-0.7

+2.2pendingpending+1.9+0.3

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sun Pharma Advanced Research Company (SPARC) has informed the stock exchanges that its Board of Directors will meet on Monday, November 02, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The trading window for directors, KMPs, designated employees and connected persons remains closed from October 01, 2026 until 48 hours after the results are declared.

Likely market impact

Routine procedural filing; investors should watch for the Q2 and H1 FY27 results on or after November 2, 2026 for earnings updates.